Results
1 -
10 of
31Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy, Investigational New Drugs Gemcitabine, Deoxynucleoside Analogs In Cancer Therapy Journal Watch, Molecular Diagnosis & Therapy Pharmacology of the paclitaxelu2013cisplatin, gemcitabineu2013cisplatin, and paclitaxelu2013gemcitabine combinations in patients with advanced non-small cell lung cancer, Cancer Chemotherapy and Pharmacology Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study, Cancer Chemotherapy and Pharmacology Pharmacokinetics and metabolism of SL-01, a prodrug of gemcitabine, in rats, Cancer Chemotherapy and Pharmacology Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas, Cancer Chemotherapy and Pharmacology Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer, Cancer Chemotherapy and Pharmacology A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors, Cancer Chemotherapy and Pharmacology Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79AC cytidine deaminase polymorphism, European Journal of Clinical Pharmacology